DIMENSIONAL FUND ADVISORS LP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Back to HALO Full portfolio

Position in HALO

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$134,419,216

-$7,190,547 QoQ

Shares Held

2,079,827

-1.2% QoQ

Ownership

1.75%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 86.30362044535434.ToString("F0")% Shared 7.98402944091023.ToString("F0")% None 5.712350113735421.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. HALO ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc. This page	2,079,827	$134,419,216

All Filings in HALO

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$134,419,216	2,079,827	-1.2%	Shares	Sole	2026-05-07
2025-12-31	$141,609,763	2,104,157	+1.2%	Shares	Sole	2026-02-12
2025-09-30	$152,431,760	2,078,426	+3.2%	Shares	Sole	2025-11-12
2025-06-30	$104,806,096	2,014,727	-0.7%	Shares	Sole	2025-08-12
2025-03-31	$129,480,697	2,029,160	+4.9%	Shares	Sole	2025-05-13
2024-12-31	$92,443,500	1,933,560	+2.5%	Shares	Sole	2025-02-13
2024-09-30	$107,941,185	1,885,765	-0.6%	Shares	Sole	2024-11-07
2024-06-30	$99,366,659	1,897,759	+12.4%	Shares	Sole	2024-08-09
2024-03-31	$68,677,153	1,688,229	+4.7%	Shares	Sole	2024-05-10
2023-12-31	$59,620,653	1,613,113	+9.9%	Shares	Sole	2024-02-07
2023-09-30	$56,048,338	1,467,234	+6.4%	Shares	Sole	2023-11-09
2023-06-30	$49,727,506	1,378,639	-1.6%	Shares	Sole	2023-08-09
2023-03-31	$53,504,645	1,401,012	-6.7%	Shares	Sole	2023-05-12
2022-12-31	$85,469,885	1,502,107	-2.0%	Shares	Sole	2023-02-09
2022-09-30	$60,634,587	1,533,500	+13.7%	Shares	Sole	2022-11-10
2022-06-30	$59,356,616	1,349,014	+14.8%	Shares	Sole	2022-08-12
2022-03-31	$46,859,558	1,175,014	+3.2%	Shares	Defined	2022-05-13
2021-12-31	$45,773,576	1,138,363	-3.8%	Shares	Defined	2022-02-09
2021-09-30	$48,149,702	1,183,621	+62.9%	Shares	Defined	2021-11-12
2021-06-30	$32,996,904	726,644	+122.7%	Shares	Defined	2021-08-12
2021-03-31	$13,602,029	326,266	+109.2%	Shares	Defined	2021-05-14
2020-12-31	$6,660,496	155,947	+67.8%	Shares	Defined	2021-03-08
2020-09-30	$2,442,226	92,931	-9.2%	Shares	Defined	2020-11-12
2020-06-30	$2,743,011	102,313	+0.1%	Shares	Defined	2020-08-13
2020-03-31	$1,839,315	102,241	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.